RealFeedApp beta
- Accrua platform launches in the US in October 2026
Accrua by Deep Longevity uses an AI model to identify 'fast agers' via blood tests and directs them to GLP-1 treatments. The US telehealth platform is scheduled to launch in October 2026.
- Field
- ageing and longevity
- What they did
- Developed a telehealth platform that uses a routine blood test and AI to calculate biological age, identifying whether a person's biological age is advancing faster than their chronological age.
- Why it matters
- This will allow doctors to prescribe treatments, such as GLP-1 medications for weight loss, only to patients whose biological age is increasing more rapidly, making the treatment more targeted.
#biological age#glp-1#deep longevity#accrua#blood test#ai model
